530 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 11 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AANATAralkylamine N-acetyltransferaseDisease related genes
Enzymes
Potential drug targets
Predicted secreted proteins
Tissue enhanced
ACSL6Acyl-CoA synthetase long-chain family member 6Cancer-related genes
Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Predicted membrane proteins
Tissue enhanced
ACVR2BActivin A receptor, type IIBCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Mixed
ADIPOQAdiponectin, C1Q and collagen domain containingCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
ADMAdrenomedullinCancer-related genes
Plasma proteins
Predicted secreted proteins
Expressed in all
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
AGMOAlkylglycerol monooxygenaseEnzymes
Predicted membrane proteins
Tissue enhanced
AGPAT21-acylglycerol-3-phosphate O-acyltransferase 2Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Expressed in all
AGRPAgouti related protein homolog (mouse)Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
AHSGAlpha-2-HS-glycoproteinCancer-related genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
AKAP5A kinase (PRKA) anchor protein 5Plasma proteins
Tissue enhanced
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ANGPTL4Angiopoietin-like 4Plasma proteins
Predicted secreted proteins
Tissue enhanced
ANKRD26Ankyrin repeat domain 26Expressed in all
ANKRD62Ankyrin repeat domain 62Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Transporters
Expressed in all
AP3S1Adaptor-related protein complex 3, sigma 1 subunitExpressed in all
APOEApolipoprotein ECancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Expressed in all
APRTAdenine phosphoribosyltransferaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Expressed in all
ATP6V0A1ATPase, H+ transporting, lysosomal V0 subunit a1Predicted membrane proteins
Transporters
Expressed in all
ATP6V0A2ATPase, H+ transporting, lysosomal V0 subunit a2Disease related genes
Plasma proteins
Predicted membrane proteins
Expressed in all
ATP6V0A4ATPase, H+ transporting, lysosomal V0 subunit a4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
ATP6V0BATPase, H+ transporting, lysosomal 21kDa, V0 subunit bPredicted membrane proteins
Expressed in all
ATP6V0D1ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1Plasma proteins
Transporters
Expressed in all
ATP6V0D2ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2
Tissue enriched
ATP6V1AATPase, H+ transporting, lysosomal 70kDa, V1 subunit AEnzymes
Plasma proteins
Transporters
Expressed in all
ATP6V1B1ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1Disease related genes
Tissue enhanced
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2FDA approved drug targets
Transporters
Expressed in all
ATP6V1C1ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1Transporters
Expressed in all
ATP6V1C2ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2Transporters
Group enriched
ATP6V1DATPase, H+ transporting, lysosomal 34kDa, V1 subunit DExpressed in all
ATP6V1E1ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1Plasma proteins
Transporters
Expressed in all
ATP6V1E2ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2
Expressed in all
ATP6V1FATPase, H+ transporting, lysosomal 14kDa, V1 subunit FTransporters
Expressed in all
ATP6V1G1ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1Plasma proteins
Transporters
Expressed in all
ATP6V1G2ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
Tissue enriched
ATP6V1G3ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3Transporters
Tissue enriched
ATP6V1HATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit HTransporters
Expressed in all
BAIAP2L1BAI1-associated protein 2-like 1
Mixed
BCAR1Breast cancer anti-estrogen resistance 1Plasma proteins
Predicted secreted proteins
Mixed
BDH13-hydroxybutyrate dehydrogenase, type 1Candidate cardiovascular disease genes
Enzymes
Mitochondrial proteins
Expressed in all
BMP8ABone morphogenetic protein 8aPredicted secreted proteins
Tissue enriched
BSCL2Berardinelli-Seip congenital lipodystrophy 2 (seipin)Disease related genes
Predicted membrane proteins
Expressed in all
CAB39Calcium binding protein 39Plasma proteins
Expressed in all
CAB39LCalcium binding protein 39-likePlasma proteins
Expressed in all
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Transporters
Tissue enriched
CAMK2GCalcium/calmodulin-dependent protein kinase II gammaEnzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched

« prev | Page of 11 | next »